What Is Preservé?
Preservé is Motiva Establishment Labs' Leading Breast Tissue Preservation approach. It is not an implant brand; it is a surgical technique and protocol set. The protocol defines which plane the implant is placed in, how the pocket is created, how tissue is preserved, and how the postoperative period is managed.
In conventional breast augmentation, the surgeon enters between muscle fibres to reach the subpectoral plane, separates breast tissue from its base, and creates a wide pocket. This method is safe and remains appropriate for the majority of patients; however, it carries a mechanical cost to tissue: oedema lasts longer, sensation may temporarily change, and drain use is common.
Preservé presents a different choice at this point. The pocket is created in a way that leaves the breast tissue as attached to its base as possible. The typical plan is subfascial (beneath the muscle fascia) or, in selected patients, subglandular (beneath the gland); pocket dimensions are confined to match the implant volume precisely. Lymphatic channels and nerve branches around the nipple-areola complex are kept outside the operative field.
This approach is not "better" for every patient — a large volume target, very thin tissue cover, or significant ptosis will require a different plan. The value of Preservé lies in the fact that when the right patient is selected, recovery time is shorter, tissue dynamics are preserved, and revision surgery, if ever needed, can be performed with less resistance.
Tissue Preservation Philosophy — The Manufacturer's Definition
Motiva positions Preservé around three practical principles:
- Minimum necessary intervention: The pocket is created in the smallest volume required for implant seating. "Precise dissection to match the implant dimensions" is preferred over "opening wide for comfortable placement".
- Preservation of anatomical structures: The lymphatic drainage channels, the 4th intercostal nerve branch supplying the nipple and areola, the pectoral muscle fascia, and glandular tissue — all are treated as lying within the protective boundaries of the operative plan.
- Implant family compatibility: The Preservé technique is compatible with all models in the Motiva implant family (Ergonomix, Ergonomix2, Round, TrueFixation). The SmoothSilk surface technology and soft gel consistency provide a natural fit within the tissue-preserving pocket.
The manufacturer restricts this approach to surgeons who have completed the accreditation programme. Accreditation is conditional on plastic surgery specialist qualification, advanced breast surgery experience, and the company's hands-on training requirements. Op. Dr. İbrahim Meyzin's accreditation certificate dated 08 February 2026 (MP-202602016) confirms that these criteria have been verified within the scope of the certificate.
The Tissue Preservation Approach — Surgical Steps
In the Preservé technique, the surgical sequence differs from classic augmentation in measured but distinct ways. The steps we follow at Nis Clinic are as follows. Nis Clinic is one of the centres offering the Motiva Preservé approach in North Cyprus with an accredited surgeon; the patient works with the same surgical team from consultation through to surgery.
Plane Selection — Subfascial or Subglandular
The first decision in the Preservé technique is the implant plane. There are two main options:
- Subfascial plane: The implant is placed beneath the thin fascial layer overlying the pectoralis major. This plane provides a smooth transition at the upper pole of the implant in cases with thin tissue cover, and offers a placement independent of muscle movement.
- Subglandular plane: In patients with adequate tissue cover, the implant can be placed directly in the plane between the breast gland and the fascia. The pocket is smaller; the muscle tissue is not touched at all.
The decision is made at the consultation stage, taking into account skin thickness, existing breast tissue volume, chest wall anatomy, and the patient's active lifestyle profile. Classic dual-plane or fully submuscular placement is not the standard preference in Preservé, because preserving the integrity of the pectoralis major is central to this philosophy.
Incision Site and Minimal Pocket Dissection
The Preservé technique does not mandate a specific incision site. The inframammary fold, periareolar (areola margin), or — in selected cases — transaxillary (axillary) approaches may all be used. The decision is made by weighing tissue volume, patient preference, and the likelihood of future revision.
Dissection differs from the "open wide and seat comfortably" logic seen in conventional augmentation. The pocket is confined precisely to match the implant dimensions. This approach has two clinical implications:
- Because the sub-tissue space is small, the risk of seroma (fluid accumulation) and haematoma is reduced.
- Because the implant is placed in a measured space, postoperative position is more predictable; late-stage complaints such as "implant migration" are less common.
During dissection, lymphatic vessels and the nerve branches supplying the nipple are preserved. This supports both early recovery of nipple sensation and the possibility that lactation (breastfeeding) potential will remain unaffected in future. It should be borne in mind that outcomes may vary between individuals.
Motiva Implant Selection
The Preservé technique is compatible with all models in the Motiva implant family. Our clinical preference most frequently falls on the following three lines:
- Ergonomix2: Soft, dynamic gel consistency; viscoelastic behaviour that follows a natural teardrop line when standing upright. Our most commonly preferred line in the subfascial and subglandular planes.
- Round: Round profile for patients targeting more pronounced upper-pole fullness.
- TrueFixation (selected cases): The line where placement stability is a priority; evaluated in revision planning.
All Motiva implants are manufactured with the SmoothSilk nano-surface; in the clinical literature this surface is referenced as a low-profile option with respect to capsular contracture and bacterial adhesion. Implant size is selected following Vectra XT 3D simulation and arrives at the operating table in its sterile packaging on the day of surgery.
Suturing, Drainage, and Operative Duration
In Preservé, because the pocket is small and dissection is measured, drains are not used in the majority of cases. In specific cases where the risk of haematoma or seroma is elevated, short-term drainage may be preferred; the decision depends on the intraoperative appearance.
Suture closure is performed layer by layer: absorbable sutures for deep tissue, intradermal technique for skin. A dressing and a specialist post-operative bra are applied on the first day.
Operative duration is typically in the range of 60–120 minutes. General anaesthesia is standard; in some selected cases a local anaesthesia plus sedation protocol may be considered. The patient is kept under observation on the day of surgery and is discharged the same day or following one night's stay.
Preservé vs Classic Silicone Implant — Comparison
A significant proportion of patients researching breast augmentation in Cyprus want to understand exactly how Preservé differs from a conventional submuscular silicone implant procedure. Which approach suits you becomes clear through the anatomical assessment at consultation.
In summary:
| Criterion | Preservé (Tissue-Preserving) | Classic Silicone Implant (Submuscular) |
|---|---|---|
| Tissue preservation approach | Pocket opened to match implant volume precisely; pectoral muscle, lymphatic network, and nerve branches kept outside the operative field | Passage between muscle fibres, wide pocket created; greater mechanical load on tissue |
| Incision | Inframammary, periareolar, or transaxillary — chosen according to tissue and patient preference | Usually inframammary; wider dissection required to pass beneath the muscle |
| Anaesthesia | General anaesthesia is standard; local anaesthesia plus sedation may be considered in selected cases | General anaesthesia |
| Recovery | Return to desk-based work mostly within 5–7 days; animation deformity does not occur | Subpectoral oedema and tightness last longer; risk of animation deformity (implant displacement during muscle movement) |
| Breastfeeding potential | Glandular tissue and milk ducts are kept outside the operative field — an approach that supports future breastfeeding potential, though the outcome cannot be guaranteed | Submuscular dissection involves less direct intervention in glandular tissue, but tissue preservation is not the central aim of this technique |
| Best suited to | Patients prioritising tissue and nerve preservation, with a future breastfeeding plan, seeking a wider volume option | Patients with a standard volume target, without a tissue-preservation priority, who value the long-established track record of submuscular placement |
This table is a guide; the definitive decision is made individually following examination.
How Preservé Differs from Mia FemTech — Which Is Right for Which Patient?
Nis Clinic offers both of Motiva Establishment Labs' distinct programmes in North Cyprus: Mia FemTech and Preservé. Patients frequently confuse the two; yet they are different things. Choosing one does not make the other "inferior" — the question is which is right for whom.
| Criterion | Mia FemTech | Preservé |
|---|---|---|
| Nature | Product + system (implant + power injection) | Surgical technique + accreditation programme |
| Implant | Ergonomix2 Diamond only | Full Motiva family (Ergonomix, Ergonomix2, Round) |
| Incision site | Transaxillary only | Inframammary / periareolar / transaxillary |
| Anaesthesia | Local + sedation | General anaesthesia (standard) |
| Plane | Prepectoral (between breast tissue and muscle) | Subfascial or subglandular |
| Volume range | 1–2 cup sizes | Wide; from modest to pronounced augmentation |
| Target patient profile | Thin-tissued, athletic, scar-free preference, small increase | Prioritises tissue preservation and future breastfeeding potential; wider volume options desired |
| Single-use device | Yes (power injector) | No |
| Cost level | Higher (system cost included) | Closer to conventional augmentation |
A straightforward decision framework:
- If natural appearance + smallest possible incision + shortest recovery are the priorities and the volume target is modest → Mia FemTech.
- For a profile where tissue and nerve preservation are central, a future pregnancy plan exists, and wider volume options are desired → Preservé.
- In patients where both options appear suitable, the decision is clarified in the consultation based on anatomy, lifestyle, and expectations.
Mia FemTech is Establishment Labs' proprietary product-plus-system line; Preservé is an accreditation programme for a surgical philosophy. Both operate under the Motiva umbrella; however, they address different clinical problems.
Recovery and Return to Daily Life
The practical promise of the Preservé technique is a shorter and more comfortable recovery compared with conventional submuscular augmentation. This is a direct consequence of keeping the mechanical load on tissue to a minimum. Individual variation exists; the timeline below is an average reference, not a guarantee.
- First 24 hours: Mild tightness and tenderness. Prescribed analgesics are generally sufficient. Sleeping on the back with the head elevated is advised.
- Days 2–3: Permission to shower is given according to suture status. Arm movements are kept restricted (activities such as brushing hair or reaching up to high shelves are deferred).
- Days 5–7: First follow-up at the clinic. Dressing change and suture check. Most patients can return to desk-based work at this stage.
- Week 2: Light social activity is permitted. For physically demanding occupations, 3–4 weeks' rest is recommended.
- Week 4: Walking and light Pilates are permitted. Surgeon approval required for upper-body weight training.
- Week 6: Sport is gradually reintegrated into normal life. Chest and shoulder exercises are added progressively.
- Month 3: Tissue settling is largely complete; final appearance becomes clearer as the 6-month mark approaches.
The approximate differences compared with conventional submuscular augmentation are as follows:
- Oedema and swelling are less pronounced and of shorter duration than with a subpectoral plane.
- "Animation deformity" (implant displacement during muscle movement) does not occur with the Preservé plane, because the implant is not beneath the muscle.
- Because pectoral muscle strength is unaffected by the operation, this is an additional benefit for athletic and active patients.
Postoperative follow-up at Nis Clinic follows this schedule: first contact within 24 hours, clinical review on days 5–7, and appointments at 1 month, 3 months, and 1 year. For our international patients, video call and photographic follow-up is maintained via WhatsApp.
Candidacy and Contraindications
Preservé delivers optimal results for a specific patient profile. It is not appropriate for every patient; this is discussed openly at the consultation. Candidacy can largely be clarified through a photographic pre-assessment before travelling to North Cyprus.
Good Candidates
- Patients who value tissue preservation: Those who want breast tissue, nipple sensation, and breastfeeding potential to remain as unaffected as possible.
- Patients planning pregnancy and lactation: Those with a future breastfeeding intention, seeking preservation of breast tissue and milk ducts.
- Active lifestyle: Those who want to return quickly to work, sport, and daily life, and wish to avoid the prolonged recovery that submuscular dissection requires.
- Athletes or patients for whom pectoral aesthetics matter: Those who want to avoid the animation deformity seen with submuscular placement.
- Flexible volume target within modest-to-pronounced range: Those who want volume options beyond the 1–2 cup-size threshold at which Mia FemTech is limited.
- Patients seeking tissue preservation in a revision setting: When implant exchange is planned following a prior augmentation, the tissue-preserving approach also facilitates subsequent revision surgery.
Situations Where an Alternative to Preservé Is Considered
- Very thin tissue cover: If skin plus breast gland cover is insufficient to conceal the implant, a subfascial/subglandular plan may increase the risk of rippling. In such cases, a submuscular or fat-graft-supported approach is recommended.
- Significant nipple ptosis (grade 2–3): Breast augmentation alone does not resolve ptosis. Mastopexy (breast lift) may be required first; this technique is explained separately on the mastopexy page.
- Active breast disease or suspicious lesion: General surgical or breast surgery evaluation takes priority.
- Uncontrolled systemic disease: Diabetes, coagulation disorder, or autoimmune disease must be medically stabilised first.
- Pregnancy or lactation: Breast surgery is not recommended during these periods.
- Very narrow chest wall combined with a very large implant target: Anatomical limits may be strained; a classic dual-plane plan may be more appropriate.
- Smoking: Must be stopped completely at least 2 weeks before the operation; otherwise tissue healing is significantly and adversely affected.
Our responsibility is this: not to tell an unsuitable patient they are suitable. Saying "X is more appropriate for you than Preservé" is clinical honesty, not a sales decision.
Op. Dr. İbrahim Meyzin — Preservé Accredited Surgeon (2026)
Op. Dr. İbrahim Meyzin was accredited as a Preservé Accredited Surgeon by Motiva Establishment Labs on 08 February 2026 (Certificate No: MP-202602016). The accreditation process was conducted under the coordination of Turkey's Preservé trainer surgeon Dr. Yakup Işık (Plastic Surgery Specialist, Istanbul) and Motiva Turkey / Mim Group General Manager Murat Oğuz. The training comprised theoretical modules, hands-on surgical practice, and case evaluations focused on tissue-preserving pocket planning.
The practical meaning of this accreditation for patients in North Cyprus is as follows: the Preservé technique is made available to surgeons who have completed the programme under Motiva's direct supervision. A claim of "we perform Preservé" at a non-accredited centre is not considered valid under Motiva's global protocol; the technical steps, implant supply chain, and follow-up protocol in that scenario fall outside the manufacturer's assurance.
Dr. Meyzin's accreditation document and certificate number are available for physical inspection at the clinic upon patient request. Detailed academic background, publications, and further certificates are on the profile page:
Nis Clinic is the only centre in North Cyprus offering both of Motiva Establishment Labs' main programmes — Mia FemTech and Preservé — under one roof. The practical implication of this dual accreditation is that patients can receive an assessment of which protocol is most suited to their anatomy and expectations from the same surgical team. We are not "locked into a single programme"; we are directly certified practitioners in both systems.
Frequently Asked Questions
What is Preservé?
What is the difference between Preservé and Mia FemTech?
In which situations is Preservé preferred over Mia FemTech?
What does tissue preservation mean in the Preservé technique?
Can I breastfeed after Preservé?
How does Preservé affect the risk of capsular contracture?
How long is the recovery after Preservé?
How much does Preservé cost?
How is a Preservé operation in North Cyprus planned?
Why is revision surgery easier after Preservé?
Approximately how much does Preservé cost?
Medical Review
Op. Dr. İbrahim MeyzinPlastic, Reconstructive and Aesthetic Surgery Specialist — Motiva Preservé Accredited Surgeon (2026)
Plastic, Reconstructive and Aesthetic Surgery Specialist — Motiva Preservé Accredited Surgeon (2026)
Last reviewed: